Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 5


Figure 5 Platelet Inhibition With Clopidogrel as Stratified by BMI

Increased body mass index (BMI) (≥25 kg/m2) remains independently associated with lower platelet inhibition with clopidogrel regardless of diabetic status or fibrinogen level. The adjusted platelet inhibition (mean ± SD) in subjects with high and normal BMI is shown. p < 0.001.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement